Intravenous iron replacement - management in general practice

Area of Science:

• General Practice
• Nutritional Medicine
• Pharmacology

Background:

• Iron deficiency is a prevalent and often underdiagnosed nutritional deficiency in Australia.
• The condition's effects can be subtle, with multifactorial causes.
• General practice encounters challenges in diagnosing and managing iron deficiency.

Purpose of the Study:

• To review the safety of parenteral iron replacement therapy, specifically intravenous (IV) iron infusions.
• To evaluate the efficacy and safety of IV iron polymaltose in a general practice setting.
• To assess IV iron polymaltose as a primary care treatment option.

Main Methods:

• A clinical evaluation of 43 consecutive adult patients receiving IV iron polymaltose.
• Low-dose IV iron polymaltose administered as slow injections diluted in normal saline.
• Treatment administered in a primary care setting for iron deficiency or depletion, with or without anemia.
• Injections given at intervals no more frequent than weekly, with serum ferritin monitoring.

Main Results:

• A total of 89 IV iron injections were administered to 43 patients.
• No serious adverse reactions were reported during the study.
• The treatment was well-tolerated by patients in the primary care setting.

Conclusions:

• Low-dose IV iron polymaltose is safe and well-tolerated in primary care for iron deficiency.
• This treatment is a potentially cost-effective alternative to specialist care and hospital admissions.
• Intravenous iron polymaltose can be effectively administered in general practice.